Location History:
- Westmount, CA (2003)
- Montreal, CA (2008 - 2014)
Company Filing History:
3 out of 274 
1 out of 295 
Years Active: 2003-2014
Title: H Uri Saragovi: Innovator in Ocular Health
Introduction
H Uri Saragovi is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of ocular health, particularly in the treatment and prevention of glaucoma and related conditions. With a total of 4 patents, his work focuses on innovative methods that leverage neurotrophic receptor modulators and gene expression regulation.
Latest Patents
Saragovi's latest patents include groundbreaking methods for treating or preventing retinal ganglion cell (RGC) death and glaucoma. One of his inventions relates to the use of modulators of neurotrophic receptors, specifically peptidomimetic cyclic compounds. These modulators can be utilized alone or in combination with other compounds to address ocular hypertension and RGC death. Another significant patent involves the treatment of glaucoma through the regulation of gene expression changes mediated by high intraocular pressure or alpha2 macroglobulin administration. This invention outlines pharmaceutical compositions that inhibit or enhance the expression of intraocular pressure-regulated early genes (IPREGs), providing a novel approach to managing chronic ocular conditions.
Career Highlights
Throughout his career, H Uri Saragovi has been associated with prestigious institutions such as McGill University and The Royal Institution for the Advancement of Learning / McGill University. His work has not only advanced scientific understanding but has also paved the way for new therapeutic strategies in ocular health.
Collaborations
Saragovi has collaborated with notable colleagues, including Lynne LeSauteur and Martin Gagnon. These partnerships have contributed to the development of his innovative patents and have fostered a collaborative environment for research and discovery.
Conclusion
H Uri Saragovi's contributions to ocular health through his patents and collaborations highlight his role as a leading inventor in the field. His innovative approaches to treating glaucoma and related conditions continue to impact the medical community positively.